Pyrimidine deoxyribonucleotide biosynthetic process

pathway activity — cross-omics
GO:0009221Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Pyrimidine deoxyribonucleotide biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Leukemia cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are BRSK1, DUT, and HDAC4, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine deoxyribonucleotide biosynthetic process activity versus BRSK1 in BLOOD_Leukemia (Pearson r = 0.40).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LeukemiaBRSK1 →+0.977+0.197.004<.00136
OVARYDUT →+0.597+0.776<.001.00135
BLOOD_LeukemiaHDAC4 →+1.383+0.224<.001.00235
SOFT_TISSUEZNF850 →+0.936+0.724.003.00835
UPPER_AERODIGESTIVE_TRACTPPM1D →+0.808+1.193<.001<.00135
BLOOD_LeukemiaPKMYT1 →+0.861+0.267<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009221 vs BRSK1 — BLOOD_Leukemia

Per-sample scatter of Pyrimidine deoxyribonucleotide biosynthetic process activity vs BRSK1 in BLOOD_Leukemia.

Explore this scatter interactively →

Exploration